Case Report: Metastatic Bronchopulmonary Carcinoid Tumor to the Pineal Region.
CNS tumor
brain metastasis
lung carcinoid
metastatic disease
neuroendocrine tumor
pineal gland
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2021
2021
Historique:
received:
30
10
2020
accepted:
08
02
2021
entrez:
19
4
2021
pubmed:
20
4
2021
medline:
17
12
2021
Statut:
epublish
Résumé
Intracranial spread of a systemic malignancy is common in advanced staged cancers; however, metastasis specifically to the pineal gland is a relatively rare occurrence. A number of primary lesions have been reported to metastasize to the pineal gland, the most common of which is lung. However, metastasis of a bronchial neuroendocrine tumor to the pineal gland is a seldom-reported entity. Here, we present a 53-year-old female who presented with worsening headaches and drowsiness. MRI brain revealed a heterogeneously enhancing partially cystic mass in the pineal region. The patient had an extensive oncologic history consisting of remote stage IIA invasive breast ductal carcinoma as well as a more recently diagnosed atypical bronchopulmonary neuroendocrine tumor with lymph node metastases. She underwent microsurgical volumetric resection of the large pineal mass and a gross total removal of the tumor was achieved. Histopathology confirmed a metastatic tumor of neuroendocrine origin and the immunohistochemical profile was identical to the primary bronchopulmonary carcinoid tumor. Eight weeks after surgery, she underwent stereotactic radiosurgical treatment to the resection cavity. At 1-year follow-up, the patient remains clinically stable without any new focal neurological deficits and without any evidence of residual or recurrent disease on postoperative MRI. Metastatic neuroendocrine tumors should be considered in the differential diagnosis of pineal region tumors and aggressive surgical resection should be considered in selected patients. Gross total tumor resection may afford excellent local disease control. We discuss the relevant literature on neuroendocrine tumors and current treatment strategies for intracranial metastases of neuroendocrine origin.
Identifiants
pubmed: 33868166
doi: 10.3389/fendo.2021.623756
pmc: PMC8044440
doi:
Types de publication
Case Reports
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
623756Informations de copyright
Copyright © 2021 Cuoco, Kortz, McCray, Guilliams, Busch, Rogers, Jarrett and Mittal.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMC Cancer. 2016 Jan 22;16:36
pubmed: 26801624
Arch Pathol Lab Med. 2010 Nov;134(11):1628-38
pubmed: 21043816
Cancer. 1997 Feb 15;79(4):813-29
pubmed: 9024720
Acta Neurochir (Wien). 1992;116(1):23-32
pubmed: 1319669
Medicine (Baltimore). 2016 May;95(18):e3622
pubmed: 27149501
Hormones (Athens). 2010 Jan-Mar;9(1):87-91
pubmed: 20363727
BMJ Case Rep. 2019 Sep 18;12(9):
pubmed: 31537610
BMC Cancer. 2019 Apr 16;19(1):362
pubmed: 30991982
J Thorac Oncol. 2019 Feb;14(2):184-192
pubmed: 30414942
Cureus. 2019 Aug 28;11(8):e5509
pubmed: 31667042
Medicine (Baltimore). 2019 Aug;98(34):e16652
pubmed: 31441839
J Neurosurg. 2013 Apr;118(4):889-95
pubmed: 23394337
Neurology. 2006 Oct 10;67(7):1303-4
pubmed: 17030775
Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):489-95
pubmed: 1995534
J Thorac Oncol. 2017 Mar;12(3):425-436
pubmed: 27890494
Lung Cancer. 2020 Jan;139:94-102
pubmed: 31759223
Cancer Biol Ther. 2020 Jun 2;21(6):503-505
pubmed: 32208886
Cancer. 2004 Dec 1;101(11):2605-13
pubmed: 15495181
Ann Thorac Cardiovasc Surg. 1999 Aug;5(4):211-9
pubmed: 10508944